These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 8408293)

  • 1. Aggregation of band 3 in hereditary ovalocytic red blood cell membranes. Electron microscopy and protein rotational diffusion studies.
    Che A; Cherry RJ; Bannister LH; Dluzewski AR
    J Cell Sci; 1993 Jul; 105 ( Pt 3)():655-60. PubMed ID: 8408293
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Decreased rotational diffusion of band 3 in Melanesian ovalocytes from Papua, New Guinea.
    Tilley L; Nash GB; Jones GL; Sawyer WH
    J Membr Biol; 1991 Apr; 121(1):59-66. PubMed ID: 1711122
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Structural organisation of band 3 in Melanesian ovalocytes.
    Tilley L; McPherson RA; Jones GL; Sawyer WH
    Biochim Biophys Acta; 1993 Mar; 1181(1):83-9. PubMed ID: 8457610
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Defective anion transport activity of the abnormal band 3 in hereditary ovalocytic red blood cells.
    Schofield AE; Reardon DM; Tanner MJ
    Nature; 1992 Feb; 355(6363):836-8. PubMed ID: 1538763
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Phosphoinositide metabolism in hereditary ovalocytic red blood cell membranes.
    Björk J; Reardon DM; Backman L
    Biochim Biophys Acta; 1997 Jun; 1326(2):342-8. PubMed ID: 9218564
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Molecular basis for membrane rigidity of hereditary ovalocytosis. A novel mechanism involving the cytoplasmic domain of band 3.
    Mohandas N; Winardi R; Knowles D; Leung A; Parra M; George E; Conboy J; Chasis J
    J Clin Invest; 1992 Feb; 89(2):686-92. PubMed ID: 1737855
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Restriction by ankyrin of band 3 rotational mobility in human erythrocyte membranes and reconstituted lipid vesicles.
    Che A; Morrison IE; Pan R; Cherry RJ
    Biochemistry; 1997 Aug; 36(31):9588-95. PubMed ID: 9236005
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Molecular defect of the band 3 protein in southeast Asian ovalocytosis.
    Liu SC; Zhai S; Palek J; Golan DE; Amato D; Hassan K; Nurse GT; Babona D; Coetzer T; Jarolim P
    N Engl J Med; 1990 Nov; 323(22):1530-8. PubMed ID: 2146504
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Both ankyrin and band 4.1 are required to restrict the rotational mobility of band 3 in the human erythrocyte membrane.
    Wyatt K; Cherry RJ
    Biochim Biophys Acta; 1992 Jan; 1103(2):327-30. PubMed ID: 1531931
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Control of band 3 lateral and rotational mobility by band 4.2 in intact erythrocytes: release of band 3 oligomers from low-affinity binding sites.
    Golan DE; Corbett JD; Korsgren C; Thatte HS; Hayette S; Yawata Y; Cohen CM
    Biophys J; 1996 Mar; 70(3):1534-42. PubMed ID: 8785311
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Band 3 mobility in camelid elliptocytes: implications for erythrocyte shape.
    McPherson RA; Sawyer WH; Tilley L
    Biochemistry; 1993 Jul; 32(26):6696-702. PubMed ID: 8329396
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Molecular characterization of the band 3 protein from Southeast Asian ovalocytes.
    Sarabia VE; Casey JR; Reithmeier RA
    J Biol Chem; 1993 May; 268(14):10676-80. PubMed ID: 8486716
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Alteration of the erythrocyte membrane via enzymatic degradation of ankyrin (band 2.1): subcellular surgery characterized by EPR spectroscopy.
    Hensley K; Postlewaite J; Dobbs P; Butterfield DA
    Biochim Biophys Acta; 1993 Feb; 1145(2):205-11. PubMed ID: 8381664
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Regulation of band 3 rotational mobility by ankyrin in intact human red cells.
    Cho MR; Eber SW; Liu SC; Lux SE; Golan DE
    Biochemistry; 1998 Dec; 37(51):17828-35. PubMed ID: 9922149
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hereditary ovalocytosis with compensated haemolysis.
    Reardon DM; Seymour CA; Cox TM; Pinder JC; Schofield AE; Tanner MJ
    Br J Haematol; 1993 Sep; 85(1):197-9. PubMed ID: 8251392
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Human erythrocyte Band-3 has an altered N terminus in malaria-resistant Melanesian ovalocytosis.
    Jones GL; Edmundson HM; Wesche D; Saul A
    Biochim Biophys Acta; 1990 Nov; 1096(1):33-40. PubMed ID: 2268683
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Band 3 protein: structure, flexibility and function.
    Wang DN
    FEBS Lett; 1994 Jun; 346(1):26-31. PubMed ID: 8206153
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Melanesian hereditary ovalocytes have a deletion in red cell band 3.
    Tanner MJ; Bruce L; Martin PG; Rearden DM; Jones GL
    Blood; 1991 Nov; 78(10):2785-6. PubMed ID: 1824272
    [No Abstract]   [Full Text] [Related]  

  • 19. Increased rotational mobility and extractability of band 3 from protein 4.2-deficient erythrocyte membranes: evidence of a role for protein 4.2 in strengthening the band 3-cytoskeleton linkage.
    Rybicki AC; Schwartz RS; Hustedt EJ; Cobb CE
    Blood; 1996 Oct; 88(7):2745-53. PubMed ID: 8839871
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Malaria and ovalocytosis--molecular mimicry?
    Husain-Chishti A; Ruff P
    Biochim Biophys Acta; 1991 Apr; 1096(3):263-4. PubMed ID: 2018800
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.